Alcohol-induced metabolomic differences in humans

Translational Psychiatry

Volumn 3, Issue , 2013, Pages

  Jaremek, M ^a   Yu, Z ^a   Mangino, M ^b   Mittelstrass, K ^a   Prehn, C ^a   Singmann, P ^a   Xu, T ^a   Dahmen, N ^c   Weinberger, K M ^d,e,k   Suhre, K ^a,f   Peters, A ^a,g   Doring A ^a   Hauner, H ^h   Adamski, J ^a,d,i   Illig, T ^a,j   Spector, T D ^b   Wang Sattler, R ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d BIOCRATES LIFE SCIENCES AG   (Austria)

^e UNIVERSITY FOR HEALTH SCIENCES   (Austria)

^f WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^j HANNOVER MEDICAL SCHOOL   (Germany)

^k Bavarian Nordic GmbH   (Germany)

more..

Author keywords

alcohol; alcoholism; biomarkers; gender; lipids; metabolomics

Indexed keywords

ACYLCARNITINE; ETHER LIPID; HIGH DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN; TRIACYLGLYCEROL; ALCOHOL; SPHINGOLIPID;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE COURSE; DRINKING BEHAVIOR; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLITE; METABOLOMICS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; ALCOHOL BLOOD LEVEL; ALCOHOL METABOLISM; BLOOD SAMPLING; ELECTROSPRAY; FOLLOW UP; RECEIVER OPERATING CHARACTERISTIC; TANDEM MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; REGISTER; SEX DIFFERENCE; STATISTICAL MODEL; TWINS; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; BODY MASS INDEX; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLOMICS; MIDDLE AGED; REGISTRIES; SEX FACTORS; YOUNG ADULT;

EID: 84880113662     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2013.55     Document Type: Article

References (71)

1. Kaddurah-Daouk R, Bogdanov MB, Wikoff WR, Zhu H, Boyle SH, Churchill E et al. Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo. Translational Psychiatry 2013; 3: e223.
2. He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C et al. Schizophrenia shows a unique metabolomics signature in plasma. Translational Psychiatry 2012; 2: e149.
3. Kaddurah-Daouk R, McEvoy J, Baillie RA, Lee D, Yao JK, Doraiswamy PM et al. Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol Psychiatry 2007; 12: 934-945. (Pubitemid 47482696)
4. Oresic M, Hyotylainen T, Herukka SK, Sysi-Aho M, Mattila I, Seppanan-Laakso T et al. Metabolome in progression to Alzheimer's disease. Translational Psychiatry 2011; 1: e57.
5. World Health O. Global status report on alcohol and health Geneva, Switzerland, 2011.
6. Kapur A, Wild G, Milford-Ward A, Triger DR. Carbohydrate deficient transferrin: a marker for alcohol abuse. BMJ 1989; 299: 427-431.
7. Peterson K. Biomarkers for alcohol use and abuse-a summary. Alcohol Res Health 2004; 28: 30-37. (Pubitemid 41595218)
8. Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 2012; 8: 615.
9. Fiehn O. Metabolomics-the link between genotypes and phenotypes. Plant Mol Biol 2002; 48: 155-171.
10. Krug S, Kastenmuller G, Stuckler F, Rist MJ, Skurk T, Sailer M et al. The dynamic range of the human metabolome revealed by challenges. FASEB J 2012; 26: 2607-2619.
11. Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wagele B et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 2011; 477: 54-60.
12. Griffiths WJ, Koal T, Wang Y, Kohl M, Enot DP, Deigner HP. Targeted metabolomics for biomarker discovery. Angew Chem Int Ed Engl 2010; 49: 5426-5445.
13. Dudley E, Yousef M, Wang Y, Griffiths WJ. Targeted metabolomics and mass spectrometry. Adv Protein Chem Struct Biol 2010; 80: 45-83.
14. Holle R, Happich M, Lowel H, Wichmann HE. KORA-a research platform for population based health research. Gesundheitswesen 2005; 67(Suppl 1): S19-S25.
15. Lowel H, Doring A, Schneider A, Heier M, Thorand B, Meisinger C. The MONICA Augsburg surveys-basis for prospective cohort studies. Gesundheitswesen 2005; 67(Suppl 1): S13-S18.
16. Wichmann HE, Gieger C, Illig T. KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 2005; 67(Suppl 1): S26-S30.
17. YuZ, ZhaiG, Singmann P, HeY, XuT, PrehnC etal. Human serum metabolic profiles are age dependent. Aging Cell2012; 11: 960-967.
18. Xu T, Holzapfel C, Dong X, Bader E, Yu Z, Prehn C et al. Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med 2013; 11: 60.
19. Mittelstrass K, Ried JS, Yu Z, Krumsiek J, Gieger C, Prehn C etal. Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet 2011; 7: e1002215.
20. Yu Z, Kastenmuller G, He Y, Belcredi P, Moller G, Prehn C et al. Differences between human plasma and serum metabolite profiles. PLoS One 2011; 6: e21230.
21. Moayyeri A, Hammond CJ, Valdes AM, Spector TD. Cohort profile: TwinsUK and Healthy Ageing Twin Study. Int J Epidemiol 2012; 42: 76-85.
22. Wang-Sattler R, Yu Y, Mittelstrass K, Lattka E, Altmaier E, Gieger C et al. Metabolic profiling reveals distinct variations linked to nicotine consumption in humans-first results from the KORA study. PLoS One 2008; 3: e3863.
23. Illig T, Gieger C, Zhai G, Romisch-Margl W, Wang-Sattler R, Prehn C et al. A genome-wide perspective of genetic variation in human metabolism 63. Nat Genet 2010; 42:137-141.
24. Jourdan C, Petersen AK, Gieger C, Doring A, Illig T, Wang-Sattler R et al. Body fat free mass is associated with the serum metabolite profile in a population-based study. PLoS One 2012; 7: e40009.
25. Zhai G, Wang-Sattler R, Hart DJ, Arden NK, Hakim AJ, Illig T et al. Serum branched-chain amino acid to histidine ratio: a novel metabolomic biomarker of knee osteoarthritis. Ann Rheum Dis 2010; 69:1227-1231.
26. Health USDo, Human S, Food, Drug A, Center for Drug E, Research. Guidance for ndustry-Bioanalytical Method Validation 2001.
27. Römisch-Margl W, Prehn C, Bogumil R, Röhring C, Suhre K, Adamski J. Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics. Metabolomics 2011; 8:133-142.
28. Filzmoser P, Maronna R, Werner M. Outlier identification in high dimensions. ComputStat Data Anal 2008; 52:1694-1711. (Pubitemid 350017776)
29. van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate Imputation by Chained Equations in R. J Stat Software 2011; 45:1-67.
30. Royston P. An extension of Shapiro and Wilks W test for normality to large samples. Appl Stat 1982; 31:115-124.
31. Bauer DF. Constructing confidence sets using rank statistics. J Am Stat Assoc 1972; 67: 687-690.
32. Agresti A. Categorical Data Analysis. 2nd edn. Chapter 3.5.1. Fisher's Exact Test for 2 x 2 Tables. Wiley: New York, NY, USA, 2002, pp 91-101.
33. Hastie TJ, Pregibon D. Generalized linear models. In: Chambers JM, Hastie TJ (eds). Statistical Models in S. Wadsworth & Brooks/Cole: Pacific Grove, CA, USA, 1992.
34. Breiman L. Random forests. Machine Learn 2001; 45: 5-32. (Pubitemid 32933532)
35. Jenkins RW, Canals D, Hannun YA. Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal 2009; 21: 836-846.
36. Liu JJ, Wang JY, Hertervig E, Cheng Y, Nilsson A, Duan RD. Activation of neutral sphingomyelinase participates in ethanol-induced apoptosis in Hep G2 cells. Alcohol Alcohol 2000; 35: 569-573.
37. Li Z, Hailemariam TK, Zhou H, Li Y, Duckworth DC, Peake DA et al. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization. Biochim BiophysActa 2007; 1771:1186-1194. (Pubitemid 47404966)
38. Deaciuc IV, Nikolova-Karakashian M, Fortunato F, Lee EY, Hill DB, McClain CJ. Apoptosis and dysregulated ceramide metabolism in a murine model of alcohol-enhanced lipopolysaccharide hepatotoxicity. Alcohol Clin Exp Res 2000; 24:1557-1565.
39. Pascual M, Valles SL, Renau-Piqueras J, Guerri C. Ceramide pathways modulate ethanol-induced cell death in astrocytes. J Neurochem 2003; 87:1535-1545. (Pubitemid 38020587)
40. Saito M, Saito M, Cooper TB, Vadasz C. Ethanol-induced changes in the content of triglycerides, ceramides, and glucosylceramides in cultured neurons. Alcohol Clin Exp Res 2005; 29:1374-1383. (Pubitemid 41243361)
41. Viktorov AV, Yurkiv VA. Effects of ethanol and lipopolysaccharide on the sphingomyelin cycle in rat hepatocytes. Bull Exp Biol Med 2008; 146: 753-755.
42. Reichel M, Greiner E, Richter-Schmidinger T, Yedibela O, Tripal P, Jacobi A et al. ncreased acid sphingomyelinase activity in peripheral blood cells of acutely intoxicated patients with alcohol dependence. Alcohol Clin Exp Res 2010; 34: 46-50.
43. Stewart SH, Reuben A, Brzezinski WA, Koch DG, Basile J, Randall PK etal. Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension. Alcohol Alcohol 2009; 44: 464-467.
44. Gustavsson L, Alling C. Formation of phosphatidylethanol in rat brain by phospholipase D. Biochem Biophys Res Commun 1987; 142: 958-963. (Pubitemid 17021126)
45. Kobayashi M, Kanfer JN. Phosphatidylethanol formation viatransphosphatidylation by rat brain synaptosomal phospholipase D. J Neurochem 1987; 48:1597-1603. (Pubitemid 17068749)
46. Mueller GC, Fleming MF, LeMahieu MA, Lybrand GS, Barry KJ. Synthesis of phosphatidylethanol-a potential marker for adult males at risk for alcoholism. Proc Natl Acad Sci USA 1988; 85: 9778-9782. (Pubitemid 19027208)
47. Helander A, Zheng Y. Molecular species of the alcohol biomarker phosphatidylethanol in human blood measured by LC-MS. Clin Chem 2009; 55: 1395-1405.
48. Nalesso A, Viel G, Cecchetto G, Mioni D, Pessa G, Favretto D et al. Quantitative profiling of phosphatidylethanol molecular species in human blood by liquid chromatography high resolution mass spectrometry. J Chromatogr A 2011; 1218: 8423-8431.
49. Croset M, Brossard N, Polette A, Lagarde M. Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J 2000; 345(Pt 1): 61-67. (Pubitemid 30060104)
50. Weltzien HU. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim Biophys Acta 1979; 559: 259-287.
51. Matsumoto T, Kobayashi T, Kamata K. Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem 2007; 14: 3209-3220.
52. Wang J, Wang H, Han H, Zhang Y, Yang B, Nattel S et al. Phospholipid metabolite 1-palmitoyl-lysophosphatidylcholine enhances human ether-a-go-go-related gene (HERG) K(+) channel function. Circulation 2001; 104: 2645-2648. (Pubitemid 33108127)
53. Holleboom AG, Kuivenhoven JA, Vergeer M, Hovingh GK, van Miert JN, Wareham NJ et al. Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study. J Lipid Res 2010; 51: 416-421.
54. Goto A, Sasai K, Suzuki S, Fukutomi T, Ito S, Matsushita T et al. Plasma concentrations of LPL and LCAT are in putative association with females and alcohol use which are independent negative risk factors for coronary atherosclerosis among Japanese. Clin Chim Acta 2003; 329: 69-76. (Pubitemid 36183483)
55. Caro AA, Cederbaum AI. Role of cytochrome P450 in phospholipase A2-and arachidonic acid-mediated cytotoxicity. Free Radic Biol Med 2006; 40: 364-375. (Pubitemid 43139672)
56. Wurst FM, Alexson S, Wolfersdorf M, Bechtel G, Forster S, Alling C et al. Concentration of fatty acid ethyl esters in hair of alcoholics: comparison to other biological state markers and self reported-ethanol intake. Alcohol Alcohol 2004; 39: 33-38. (Pubitemid 38111670)
57. Salem RO, Refaai MA, Cluette-Brown JE, Russo JW, Laposata M. Fatty acid ethyl esters in liver and adipose tissues as postmortem markers for ethanol intake. Clin Chem 2001; 47: 722-725. (Pubitemid 32275816)
58. Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 2001; 48: 198-205. (Pubitemid 32141843)
59. Smedman AE, Gustafsson IB, Berglund LG, Vessby BO. Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. Am J Clin Nutr 1999; 69: 22-29. (Pubitemid 29031247)
60. Wu Z, Palmquist DL. Synthesis and biohydrogenation of fatty acids by ruminal microorganisms in vitro. J Dairy Sci 1991; 74: 3035-3046.
61. Wolk A, Vessby B, Ljung H, Barrefors P. Evaluation of a biological marker of dairy fat intake. Am J Clin Nutr 1998; 68: 291-295. (Pubitemid 28355645)
62. Ruf T, Nagel G, Altenburg HP, Miller AB, Thorand B. Food and nutrient intake, anthropometric measurements and smoking according to alcohol consumption in the EPIC Heidelberg study. Ann Nutr Metab 2005; 49: 16-25. (Pubitemid 41094829)
63. Kesse E, Clavel-Chapelon F, Slimani N, van Liere M. Do eating habits differ according to alcohol consumption? Results of a study of the French cohort of the European Prospective Investigation into Cancer and Nutrition (E3N-EPIC). Am J Clin Nutr 2001; 74: 322-327. (Pubitemid 32802017)
64. Nagan N, Zoeller RA. Plasmalogens: biosynthesis and functions. Prog Lipid Res 2001; 40: 199-229. (Pubitemid 32220187)
65. Snyder F. Platelet-activating factor: the biosynthetic and catabolic enzymes. Biochem J 1995; 305(Pt 3): 689-705.
66. Dimmitt SB, Rakic V, Puddey IB, Baker R, Oostryck R, Adams MJ et al. The effects of alcohol on coagulation and fibrinolytic factors: a controlled trial. Blood Coagul Fibrinolysis 1998; 9: 39-45. (Pubitemid 28144415)
67. Hillbom M, Neiman J. Platelet thromboxane formation capacity after ethanol withdrawal in chronic alcoholics. Haemostasis 1988; 18: 170-178.
68. Mikhailidis DP, Jenkins WJ, Barradas MA, Jeremy JY, Dandona P. Platelet function defects in chronic alcoholism. Br Med J (Clin Res Ed) 1986; 293: 715-718. (Pubitemid 16025283)
69. Salem RO, Laposata M. Effects of alcohol on hemostasis. Am J Clin Pathol 2005; 123(Suppl): S96-105.
70. Kaufman DW, Kelly JP, Wiholm BE, Laszlo A, Sheehan JE, Koff RS et al. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol 1999; 94: 3189-3196.
71. Ruckert IM, Heier M, Rathmann W, Baumeister SE, Doring A, Meisinger C. Association between markers of fatty liver disease and impaired glucose regulation in men and women from the general population: the KORA-F4-study. PLoS One 2011; 6: e22932.